SATIVEX AS ADD-ON THERAPY VS. FURTHER OPTIMIZED FIRST-LINE ANTISPASTICS THE S A V A N T TRIAL
Phase of Trial: Phase IV
Latest Information Update: 24 Jun 2017
At a glance
- Drugs Nabiximols (Primary)
- Indications Muscle spasticity
- Focus Therapeutic Use
- Acronyms SAVANT
- Sponsors Almirall Hermal GmbH
- 23 Jun 2017 Status changed from recruiting to completed.
- 11 Mar 2017 This trial has been completed in Austria.
- 15 Mar 2016 New trial record